Vanguard Personalized Indexing Management’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Vanguard Personalized Indexing Management's BNTX Position: Q4 2025 in Review
Vanguard Personalized Indexing Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 2,164 shares — an estimated $213K sold.
Vanguard Personalized Indexing Management first reported a position in BNTX in Q4 2021 and held it in 12 quarters. The position peaked at $445K in Q3 2023. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.
- Vanguard Personalized Indexing Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
- Vanguard Personalized Indexing Management sold 2,164 BioNTech shares in Q4 2025, an estimated $213K.
- Vanguard Personalized Indexing Management first reported a position in BioNTech in Q4 2021 and held it in 12 quarters.
- Vanguard Personalized Indexing Management's BioNTech position peaked at $445K in Q3 2023.
- 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.
Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.